The Diary of a CEOCognitive Decline Expert: The Disease That Starts in Your 30s but Kills You in Your 70s
CHAPTERS
- 0:00 – 2:38
Creatine as a brain-protection supplement (sleep loss, stroke, concussion)
Louisa opens with an energetic case for creatine as a high-ROI supplement for brain energy and resilience. She cites evidence for mitigating sleep deprivation effects and supporting patients with Alzheimer’s-related fatigue and cognition.
- •Creatine may blunt cognitive/brain effects of sleep deprivation
- •Potential protective effects for concussion, stroke, and stress
- •Pilot data in Alzheimer’s patients: preserved cognition, more energy, more exercise
- •Louisa’s clinical/research background and motivation to focus on Alzheimer’s
- 2:38 – 5:25
Why Alzheimer’s is urgent—and largely preventable
The conversation frames Alzheimer’s as a growing global crisis that disproportionately affects women. Louisa argues most cases are driven by modifiable lifestyle factors rather than deterministic genetics.
- •60M people worldwide; projected to triple by 2050
- •Women comprise ~70% of cases; being female is a risk factor
- •Alzheimer’s isn’t ‘normal aging’
- •Claim: ~95% of current cases could be prevented via lifestyle
- 5:25 – 7:44
Alzheimer’s vs. dementia, and how it starts decades before symptoms
Louisa explains dementia as an umbrella term and positions Alzheimer’s as a midlife disease process that begins silently. She outlines how brain decline compounds from common modern stressors long before diagnosis.
- •Dementia types: Alzheimer’s, frontotemporal, Lewy body, vascular, Parkinson’s dementia
- •Pathology begins in 30s; symptoms often appear in late 60s/70s
- •Brain energy demands and vascular richness make it vulnerable
- •Sleep loss, diet, inactivity, toxins compound damage over time
- 7:44 – 8:38
What brain atrophy looks like (healthy brain vs. Alzheimer’s)
Using brain imagery, Louisa describes cortical thinning, enlarged ventricles, and overall shrinkage. This segment grounds the discussion in visible structural changes linked to cognitive impairment.
- •Healthy brain: thicker cortex/gray matter, smaller ventricles
- •Alzheimer’s: thinning cortex, widened spaces, larger ventricles
- •Atrophy relates to neuronal/synaptic loss
- •Mild Cognitive Impairment (MCI) as a pre-dementia state
- 8:38 – 11:52
Cognitive reserve: why some 60-year-olds stay razor-sharp
Steven asks why cognitive aging varies so much, leading to the concept of cognitive reserve. Louisa explains reserve as the brain’s capacity built through rich connections and sustained challenge.
- •Cognitive reserve parallels physical ‘reserve’ like VO2 max
- •Novelty and learning build synaptic connections over time
- •Amyloid burden doesn’t perfectly predict symptoms; reserve moderates impact
- •Connections weaken when not used (use-it-or-lose-it principle)
- 11:52 – 13:44
Building reserve: exercise, reading/handwriting—and why scrolling harms focus
Louisa contrasts high-value brain behaviors with low-value dopamine-driven habits. She emphasizes exercise as the strongest lever, with reading/handwriting supporting preservation, while constant scrolling erodes sustained attention.
- •Reading and handwriting linked to preserved cognition in older age
- •Exercise is the most potent stimulus for brain health and reserve
- •Social media scrolling trains short dopamine loops, reducing sustained focus
- •Public health gap: many people under-exercise vs. guidelines
- 13:44 – 17:20
Strength training for the brain: trials, genetics, and ‘strong legs’
Louisa highlights resistance training as a top intervention for slowing cognitive decline, citing MCI studies and twin data. She also explains genetic risk (APOE4) while emphasizing risk is modifiable.
- •SMART trial: resistance training improved processing speed and intelligence in MCI
- •Gray vs. white matter basics; white matter lesions over time
- •APOE4 elevates risk (especially in women) but isn’t destiny
- •Twin study: stronger twin (leg power) had larger brain/gray matter and better cognition
- 17:20 – 23:26
Mechanisms: myokines, BDNF, inflammation, and ‘lift heavy’ neural drive
This chapter explains why heavy resistance training uniquely benefits the brain. Louisa connects muscle contractions to myokines (e.g., irisin, IL-6), neurogenesis signals, and anti-inflammatory effects.
- •Brain benefits require heavy lifting (~80% 1RM) for strongest neural effects
- •Myokines from muscle signal the brain; support hippocampal health
- •BDNF supports neuron growth; irisin helps BDNF expression
- •Exercise-induced IL-6 can act anti-inflammatory; links to anti-cancer signaling
- •Heavier loads require more motor cortex ‘real estate’ and neural drive
- 23:26 – 25:39
Sedentary living as a disease—and the ‘10 air squats per hour’ fix
Steven brings up ‘active sedentary’ risk: exercising but sitting all day. Louisa offers a practical countermeasure—hourly movement snacks—to reduce metabolic harm from prolonged sitting.
- •Sitting 10+ hours/day raises cardiovascular risk even if you exercise
- •Hourly movement breaks can offset sedentary physiology
- •10 air squats each hour suggested as a simple intervention
- •Movement helps blunt post-meal glucose spikes and improves metabolic health
- 25:39 – 35:20
Aerobic training, Zone 2 vs Zone 5, and remodeling the heart for brain health
Louisa reframes cardio around time efficiency and intensity, advocating VO2-max work (Zone 5) alongside resistance training. She discusses Ben Levine’s study showing dramatic heart ‘rejuvenation,’ emphasizing midlife as the key window.
- •Zone 2 definition and benefits; Zone 3–5 produce lactate (brain fuel signal)
- •Argument: women may get less ROI from Zone 2; prioritize higher intensity + strength
- •Outdoor running adds sensory/novelty benefits, but Zone 5 may be stronger stimulus
- •Levine study: ~4 hours/week over 2 years remodeled hearts by ~20 years
- •Norwegian 4x4 protocol for VO2 max; heart plasticity declines after ~65
- 35:20 – 40:16
Blood pressure, capillaries, and protecting the blood–brain barrier
Louisa links vascular health directly to cognition via capillary integrity and the blood–brain barrier. She explains how hypertension accelerates microvascular damage and highlights home monitoring and clinical targets.
- •Hypertension can kill brain capillaries and degrade the blood–brain barrier (‘leaky brain’)
- •SPRINT trial supports tighter BP management (~120/80) to preserve cognition/gray matter
- •Daily BP monitoring is cheap and actionable
- •Lifestyle levers: exercise, sleep, stress/cortisol management; meds when needed
- 40:16 – 44:10
Why Alzheimer’s kills—and what Louisa would do if diagnosed
The discussion shifts from memory loss to the real causes of death in advanced Alzheimer’s. Louisa then outlines an aggressive mitigation playbook focused on exercise, diet, lipids, and social engagement.
- •Alzheimer’s is irreversible after diagnosis; MCI progression can be slowed
- •End-stage risks: swallowing failure/asphyxiation, falls, systemic complications
- •Ketogenic strategy: ketones as alternative fuel during brain ‘metabolic crisis’
- •High omega-3 intake, lipid control, social/cognitive engagement as priorities
- 44:10 – 52:54
Women, menopause, and brain energy: estrogen, ketones, and HRT nuance
Louisa explains the menopause-related drop in brain glucose metabolism and its link to brain fog and sleep disruption. She addresses hormone replacement therapy cautiously—potential benefits, but incomplete RCT evidence for dementia prevention.
- •Perimenopause/menopause: ~30% reduction in brain glucose metabolism
- •Brain fog and sleep disruption via hot flashes/night sweats increase Alzheimer’s risk
- •Ketogenic diet proposed as support during ‘brain energetic crisis’
- •HRT: may reduce Alzheimer’s risk (~up to 30%) but evidence is not definitive
- •Estrogen supports sleep and muscle/bone (indirectly lowering dementia risk); delivery options discussed
- 52:54 – 1:01:22
Core biology: amyloid, tau, and the role of deep sleep (glymphatic cleaning)
Louisa clarifies what distinguishes Alzheimer’s: amyloid beta and tau pathology. She argues amyloid may be protective, but poor deep sleep impairs clearance, while stress and hormonal shifts promote tau tangles.
- •History: first case (Auguste Deter) and early amyloid focus
- •Amyloid clearance occurs during deep sleep via the glymphatic system
- •Anti-amyloid drugs can cause microhemorrhages; amyloid may be antimicrobial/protective
- •Tau phosphorylation leads to neurofibrillary tangles and axonal collapse
- •Estrogen may block enzymes that phosphorylate tau; sleep/stress worsen pathology
- 1:01:22 – 1:09:16
Sleep as the most underrated prevention tool—and practical protocols
They discuss how chronic short sleep compounds risk and can’t be repaid on weekends, though ‘sleep banking’ may help ahead of known deprivation. Louisa shares actionable tactics spanning supplements, temperature, circadian cues, and wind-down routines.
- •One night sleep deprivation may raise amyloid risk ~4–5%; compounding matters
- •You can’t fully ‘catch up’ sleep debt; consider sleep banking before flights/events
- •Differentiate trouble falling asleep vs. staying asleep
- •Tools: GABA for racing mind; glycine for temperature regulation; adaptogens (ashwagandha/rhodiola) for stress
- •Circadian hygiene: dim/red light, reduce late-night stimulation, cool room/feet, temperature-controlled mattress
- 1:09:16 – 1:26:51
Supplements for brain aging: omega-3, vitamin D—and a deep dive on creatine dosing & safety
Louisa explains why omega-3 quality control matters and how DHA supports membranes and inflammation reduction. She then expands on vitamin D’s dementia associations and returns to creatine—higher brain-targeted dosing, timing, and kidney-lab misconceptions.
- •Omega-3: oxidation/rancidity is common; look for credible certification; refrigerate
- •DHA supports synaptic membrane fluidity and anti-inflammatory effects
- •Vitamin D: receptors in memory areas; deficiency linked to higher dementia risk
- •Creatine: brain benefits may require >5g (muscle saturates first); Alzheimer’s pilot used ~20g/day
- •Safety: creatinine can rise with muscle/stress; consider cystatin C for kidney assessment; look for NSF/Creapure standards
- 1:26:51 – 1:29:47
Testing and early detection: lipoprotein(a), Alzheimer’s blood biomarkers, and processing-speed demo
Louisa shares her frequent lab-testing routine and flags overlooked markers for cardiovascular risk. She also describes emerging blood tests for amyloid/tau and demonstrates quick cognitive assessments with color-word interference cards.
- •Routine lab cadence: every 3–4 months; biological age testing annually
- •Under-tested marker: lipoprotein(a) for inherited cardiovascular risk
- •Blood biomarkers: p-tau217 and amyloid beta approaching PET-like accuracy for detection
- •Processing speed test (Stroop-style) illustrates cognitive load and interference
- •Emphasis on measurable, trackable risk signals before symptoms escalate
- 1:29:47 – 1:35:52
5-minute neuro drills: tennis ball + eye patch to train reaction time and reserve
Steven participates in coordination drills that increase difficulty by restricting vision and adding balance demands. Louisa connects these tasks to executive function, visual cortex training, and building cognitive reserve via challenging novelty.
- •Throw/catch variations train processing speed and hand–eye coordination
- •Eye patch increases neural demand by reducing visual input
- •Single-leg stance engages cerebellum and spatial awareness
- •Racket sports and coordination work as powerful cognitive training tools
- •Goal: strengthen neural networks and reduce reaction time (used with elite athletes)
- 1:35:52 – 1:44:38
The ‘willpower’ brain: AMCC growth through doing hard things—and modern ‘brain rot’ risks
Louisa and Steven explore the anterior midcingulate cortex (AMCC) as a resilience/will-to-live region that grows only under challenge. They tie this to goal-setting failures, sedentary comfort, and cognitive offloading to AI.
- •AMCC is larger in ‘SuperAgers’ and athletes; shrinks with avoidance/sedentary living
- •Growth occurs when you do things you dislike but choose anyway (true resistance)
- •Willpower reframed as neurobiology; challenge creates adaptive capacity
- •AI and endless scrolling can reduce mental effort and skill retention (cognitive offloading)
- •Cycle: avoiding hard things reduces capacity to do hard things again
- 1:44:38 – 1:54:36
Why Louisa is obsessed: women’s underrepresentation, caregiving burden, and her grandmother’s story
Louisa explains her personal and political motivations—women’s symptoms being dismissed, lack of access, and systemic confusion in healthcare. Her grandmother’s experience with late-stage cancer catalyzed her drive to prevent avoidable suffering.
- •Women underrepresented in research; often downplay symptoms or avoid care
- •Care access disparities and health messaging confusion deepen vulnerability
- •Personal origin: grandmother’s late diagnosis and ‘nothing you can do’ moment
- •Anger/frustration fuels mission to improve prevention and advocacy
- •Aim: give women agency with evidence-based tools before it’s too late
- 1:54:36 – 2:04:42
Success, brain-state control, and closing reflections on meaning, faith, and hope
The final stretch turns philosophical: what success means, the costs of obsession, and preserving memories as the core of a life well lived. They end with a faith discussion—how medicine can’t answer everything—and Steven’s closing appreciation.
- •Success defined as controlling brain states: switch on/off and recover (flow)
- •Tradeoffs of ambition: health, distance from family, missed events
- •Alzheimer’s framed as loss of self and memory—what makes life meaningful
- •God/faith discussed as support when medicine can’t explain outcomes
- •Closing gratitude and call to use knowledge to preserve brain and identity
